Recent outing by young pitcher reignites debate on pitch counts

Rep. Yoo Il-ho Rep. Kim Jae-won Many members of a pro-President Park Geun-hye faction have been given top posts in the ruling Saenuri Party during its structural reorganization. The party completed filling its leadership posts Monday. Third-term ...

SEOUL, May 27 (Yonhap) -- South Korean Lee Il-hee earned her first career LPGA Tour victory in a rain-shortened tournament in the Bahamas local time on Sunday. Lee won the Pure Silk-Bahamas LPGA Classic at the Ocean Club Golf Course with a ...

North Korea's proposal of high-level talks with the U.S. was only the latest in a series of developments that have baffled North Korea watchers. The North's recent antics have given the impression of a desperately flailing foreign policy, whether ...

North Korea blamed South Korea for the cancellation of talks planned for this week on reopening a joint factory park, a setback to prospects of improved economic ties and reduced tensions with Kim Jong Un's regime. North Korea was compelled to ...

South Korean TV entertainment shows are usually dominated by comedians and young entertainers, but a unique show featuring senior actors is trying to buck the trend. Ggotboda Halbae (Gramps over Flowers), the newest show on cable TV channel tvN's, ...

Park In-bee affirmed her position as the world's No. 1 golfer with her second major title of the season. The 24-year-old Korean golfer sank a 20-foot birdie putt on the third sudden-death playoff hole against Catriona Matthew of Scotland to win ...

Leading second-round scores here on Saturday in the LPGA Championship (USA unless noted, par-72): 138 - Morgan Pressel 68-70 140 - Park In-Bee (KOR) 72-68, Chella Choi (KOR) 67-73 141 - Sarah Jane Smith (AUS) 72-69, Amy Yang (KOR) 71-70, Shin ...

Morgan Pressel fired four birdiesin a two-under 70 on Saturday to take a two-stroke lead over world number one Park In-Bee and Chella Choi after two rounds of the LPGA Championship. Morgan Pressel lines up a putt on the third green during the ...

Chemokines ligands to at least one of CCR1, CCR2, CCR3, or CCR5 can be used to home stem cells for therapeutic applications. Description of the Invention FIELD OF THE INVENTION The present invention relates to chemokines and particularly to ...